Literature DB >> 6500230

Amplification of the c-myc oncogene in human stomach cancers.

F Nakasato, H Sakamoto, M Mori, K Hayashi, Y Shimosato, M Nishi, S Takao, K Nakatani, M Terada, T Sugimura.   

Abstract

Amplified c-myc oncogene was found in the DNAs of 2 of 11 human stomach cancers transplanted into nude mice; the amplification was 8- to 10-fold in one tumor and 13- to 15-fold in the other. Both tumors in which the c-myc oncogene was amplified were poorly differentiated adenocarcinomas, but there was no clear-cut correlation between the histological types or growth rates of the tumors and amplification of the c-myc oncogene. No amplification of the c-myc gene was detected in DNAs from 4 cultured stomach cancer cell lines, 19 primary stomach cancers or 11 metastases to lymph nodes from human stomach cancers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500230

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  12 in total

Review 1.  Gastric carcinogenesis: diet as a causative factor.

Authors:  T Sugimura; K Wakabayashi
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells.

Authors:  M Shibuya; J Yokota; Y Ueyama
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

Review 3.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

4.  myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.

Authors:  B E Johnson; D C Ihde; R W Makuch; A F Gazdar; D N Carney; H Oie; E Russell; M M Nau; J D Minna
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

5.  K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes.

Authors:  Y Hattori; H Odagiri; H Nakatani; K Miyagawa; K Naito; H Sakamoto; O Katoh; T Yoshida; T Sugimura; M Terada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

6.  Frequency and spectrum of p53 mutations in gastric cancer--a molecular genetic and immunohistochemical study.

Authors:  C Poremba; D W Yandell; Q Huang; J B Little; W Mellin; K W Schmid; W Böcker; B Dockhorn-Dworniczak
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.

Authors:  J F Contrera; J J DeGeorge
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

8.  Isolation of an amplified DNA sequence in stomach cancer.

Authors:  H Nakatani; H Sakamoto; T Yoshida; J Yokota; E Tahara; T Sugimura; M Terada
Journal:  Jpn J Cancer Res       Date:  1990-08

9.  Over-expression of the c-myc proto-oncogene in colorectal carcinoma.

Authors:  D R Smith; T Myint; H S Goh
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

10.  Amplification of the hst-1 gene in human esophageal carcinomas.

Authors:  T Tsuda; H Nakatani; T Matsumura; K Yoshida; E Tahara; T Nishihira; H Sakamoto; T Yoshida; M Terada; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1988-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.